Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Clinical and Biological Strokes Collection in Reunion Island

ID
Name
2020/CHU/40
Description
Cross-sectional regional multicenter hospital study of all neurological events (stroke, AIT and mimics) for diagnostic and prognostic purposes. Cost of illness study.
Trial arms
Trial start
2021-06-22
Estimated PCD
2023-06-21
Trial end
2023-06-21
Status
Completed
Treatment
Biological Collection
A blood sample (10 ml) will be taken for each patient included in the study.
Arms:
Intervention
Size
795
Primary endpoint
clinico-biological score
24 hours after the stroke
Eligibility criteria
Inclusion Criteria: * affiliated to a social security scheme * clinical signs suggestive of stroke : hemiparesis or hemiplegia, unilateral sensory disorder, language disorder, balance disorder, dizziness, loss of total or partial bilateral or monocular vision, sudden neurological deficit Exclusion Criteria: * current pregnancy * Recent clinical history of head trauma * patients aged \< 18 years old * patient under guardianship or curatorship * Person deprived of liberty
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'DIAGNOSTIC', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 795, 'type': 'ACTUAL'}}
Updated at
2023-09-29

1 organization

1 product

1 indication

Organization
Centre Hospitalier Universitaire de la Réunion
Product
Biological Collection
Indication
stroke